RU98118574A - METHOD OF DESTRUCTION OF UNWANTED TARGET CELLS - Google Patents
METHOD OF DESTRUCTION OF UNWANTED TARGET CELLSInfo
- Publication number
- RU98118574A RU98118574A RU98118574/14A RU98118574A RU98118574A RU 98118574 A RU98118574 A RU 98118574A RU 98118574/14 A RU98118574/14 A RU 98118574/14A RU 98118574 A RU98118574 A RU 98118574A RU 98118574 A RU98118574 A RU 98118574A
- Authority
- RU
- Russia
- Prior art keywords
- immunotoxins
- cells
- fragments
- mos31
- antibodies
- Prior art date
Links
- 210000004027 cells Anatomy 0.000 claims 11
- 231100000608 Immunotoxin Toxicity 0.000 claims 10
- 108010004484 Immunotoxins Proteins 0.000 claims 10
- 108090001123 antibodies Proteins 0.000 claims 10
- 102000004965 antibodies Human genes 0.000 claims 10
- 239000002596 immunotoxin Substances 0.000 claims 10
- 230000002637 immunotoxin Effects 0.000 claims 10
- 231100000765 Toxin Toxicity 0.000 claims 5
- 239000000427 antigen Substances 0.000 claims 5
- 108091007172 antigens Proteins 0.000 claims 5
- 102000038129 antigens Human genes 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 239000003053 toxin Substances 0.000 claims 5
- 108020003112 toxins Proteins 0.000 claims 5
- 101700010580 FLO11 Proteins 0.000 claims 2
- 102100006037 MUC1 Human genes 0.000 claims 2
- 101700052761 MUC1 Proteins 0.000 claims 2
- 102100006042 MUC17 Human genes 0.000 claims 2
- 101700010570 MUC17 Proteins 0.000 claims 2
- 102100013951 MUC2 Human genes 0.000 claims 2
- 101700036633 MUC2 Proteins 0.000 claims 2
- 101700075415 MUC3A Proteins 0.000 claims 2
- 108010077397 Pseudomonas aeruginosa toxA protein Proteins 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000003211 malignant Effects 0.000 claims 2
- 210000000683 Abdominal Cavity Anatomy 0.000 claims 1
- 210000004369 Blood Anatomy 0.000 claims 1
- 210000001185 Bone Marrow Anatomy 0.000 claims 1
- 210000000988 Bone and Bones Anatomy 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 102100016492 CD34 Human genes 0.000 claims 1
- 108060001251 CD34 Proteins 0.000 claims 1
- 210000004253 Multipotent Stem Cells Anatomy 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 210000004940 Nucleus Anatomy 0.000 claims 1
- 210000003281 Pleural Cavity Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 201000009030 carcinoma Diseases 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 claims 1
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO961031 | 1996-03-13 | ||
NO961031A NO961031D0 (en) | 1996-03-13 | 1996-03-13 | Procedure for killing unwanted target cells |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98118574A true RU98118574A (en) | 2000-07-20 |
RU2182493C2 RU2182493C2 (en) | 2002-05-20 |
Family
ID=19899150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98118574/14A RU2182493C2 (en) | 1996-03-13 | 1997-03-12 | Method for eliminating undesirable target cells |
Country Status (18)
Country | Link |
---|---|
US (1) | US7198787B2 (en) |
EP (1) | EP0954329B1 (en) |
JP (1) | JP2000507230A (en) |
CN (1) | CN1218411A (en) |
AT (1) | ATE222122T1 (en) |
AU (1) | AU710184B2 (en) |
BR (1) | BR9708049A (en) |
CA (1) | CA2248620A1 (en) |
DE (1) | DE69714775T2 (en) |
HU (1) | HUP9901597A3 (en) |
IL (1) | IL126014A0 (en) |
NO (1) | NO961031D0 (en) |
NZ (1) | NZ331763A (en) |
PL (1) | PL328804A1 (en) |
RU (1) | RU2182493C2 (en) |
SK (1) | SK125798A3 (en) |
TR (1) | TR199801795T2 (en) |
WO (1) | WO1997033611A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
US7496291B2 (en) * | 2006-03-21 | 2009-02-24 | Hewlett-Packard Development Company, L.P. | Method and apparatus for interleaved image captures |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
EP2589668A1 (en) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Rare cell analysis using sample splitting and DNA tags |
WO2007147074A2 (en) | 2006-06-14 | 2007-12-21 | Living Microsystems, Inc. | Use of highly parallel snp genotyping for fetal diagnosis |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
DK2334812T3 (en) | 2008-09-20 | 2017-03-27 | Univ Leland Stanford Junior | Non-invasive diagnosis of fetal aneuploidy by sequencing |
RU2539832C2 (en) | 2008-10-17 | 2015-01-27 | Дана-Фарбер Кэнсер Инститьют, Инк. | Muc-1 protein cytoplasmic domain peptides as cancer inhibitors |
EP2435062A4 (en) | 2009-05-27 | 2013-01-02 | Dana Farber Cancer Inst Inc | Inhibition 0f inflammation using antagonists of muc1 |
CN102127148B (en) * | 2010-01-14 | 2013-04-03 | 中国农业科学院北京畜牧兽医研究所 | Polypeptide in cluster-of-differentiation part on surface of vascular endothelial cell and use thereof |
BR112013028537A2 (en) * | 2011-05-06 | 2017-01-17 | Us Gov Health & Human Serv | recombinant mesotoxin targeting immunotoxin |
CN107748256B (en) * | 2017-10-11 | 2020-04-14 | 厦门骁科码生物科技有限公司 | Liquid biopsy detection method for circulating tumor cells |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4219411A (en) | 1978-09-18 | 1980-08-26 | California Institute Of Technology | Cell sorting apparatus |
US4230685A (en) | 1979-02-28 | 1980-10-28 | Northwestern University | Method of magnetic separation of cells and the like, and microspheres for use therein |
US4510244A (en) | 1980-04-17 | 1985-04-09 | The Board Of Trustees Of The Leland Stanford Jr. University | Cell labeling with antigen-coupled microspheres |
AU563827B2 (en) | 1982-07-01 | 1987-07-23 | Millipore Corp. | Filtration apparatus |
US4659678A (en) | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
US4704255A (en) | 1983-07-15 | 1987-11-03 | Pandex Laboratories, Inc. | Assay cartridge |
US4920061A (en) | 1984-03-02 | 1990-04-24 | The University Of Texas System | Biological magnetic colloids |
US4752569A (en) | 1984-06-21 | 1988-06-21 | The Regents Of The University Of California | Sialylated Lewisx epitope, antibodies and diagnosis |
US5019497A (en) | 1984-11-09 | 1991-05-28 | Lennart Olsson | Human squamous lung carcinoma cell specific antigens and antibodies |
US4710472A (en) | 1985-09-25 | 1987-12-01 | The United States Of America As Represented By The Secretary Of The Navy | Magnetic separation device |
US5076950A (en) | 1985-12-20 | 1991-12-31 | Syntex (U.S.A.) Inc. | Magnetic composition for particle separation |
EP0241042A3 (en) | 1986-04-11 | 1988-05-04 | Hitachi, Ltd. | A method for cell analysis |
US4895706A (en) | 1986-10-28 | 1990-01-23 | Costar Corporation | Multi-well filter strip and composite assemblies |
US4857452A (en) | 1986-12-04 | 1989-08-15 | E. I. Du Pont De Nemours And Company | Assay for carcinoma of breast, colon and ovary |
US5194300A (en) | 1987-07-15 | 1993-03-16 | Cheung Sau W | Methods of making fluorescent microspheres |
US5322678A (en) | 1988-02-17 | 1994-06-21 | Neorx Corporation | Alteration of pharmacokinetics of proteins by charge modification |
US5256532A (en) | 1988-05-02 | 1993-10-26 | Zynaxis Technologies, Inc. | Methods, reagents and test kits for determination of subpopulations of biological entities |
FR2638848B1 (en) | 1988-11-04 | 1993-01-22 | Chemunex Sa | METHOD OF DETECTION AND / OR DETERMINATION IN A LIQUID OR SEMI-LIQUID MEDIUM OF AT LEAST ONE ORGANIC, BIOLOGICAL OR MEDICINAL SUBSTANCE, BY AN AGGLUTINATION METHOD |
AU4746590A (en) | 1988-12-28 | 1990-08-01 | Stefan Miltenyi | Methods and materials for high gradient magnetic separation of biological materials |
US5185254A (en) * | 1988-12-29 | 1993-02-09 | The Wistar Institute | Gene family of tumor-associated antigens |
GB8905001D0 (en) | 1989-03-04 | 1989-04-19 | Univ Leicester | Screening for natural products of microbial metabolism |
WO1990010692A1 (en) | 1989-03-15 | 1990-09-20 | University Of Florida | Monoclonal antibody for use in detection and treatment of childhood leukemia |
US5081030A (en) | 1989-04-25 | 1992-01-14 | The Johns Hopkins University | Release of cells from affinity matrices |
DE3919923A1 (en) | 1989-06-19 | 1990-12-20 | Behringwerke Ag | MAGNETIC PROTEIN CONJUGATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
DE3919873A1 (en) | 1989-06-19 | 1990-12-20 | Behringwerke Ag | MAGNETIC PROTEIN CONJUGATES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
GB8916859D0 (en) | 1989-07-24 | 1989-09-06 | Dynal As | Hapten linking |
ES2152216T3 (en) * | 1989-12-14 | 2001-02-01 | Sloan Kettering Inst Cancer | THERAPEUTIC USES OF THE HYPERVARIABLE REGION OF THE M195 MONOCLONAL ANTIBODY AND CONSTRUCTS OF THE SAME. |
GB8929297D0 (en) | 1989-12-29 | 1990-02-28 | Dynal As | Method of separation |
GB9007966D0 (en) | 1990-04-09 | 1990-06-06 | Dynal As | Antigen/anti-antigen cleavage |
US5200084A (en) | 1990-09-26 | 1993-04-06 | Immunicon Corporation | Apparatus and methods for magnetic separation |
US5340719A (en) | 1990-11-23 | 1994-08-23 | Corporation Coulter | Method and apparatus for optically screening microscopic cells |
JPH05107249A (en) | 1991-02-04 | 1993-04-27 | Toyobo Co Ltd | High-sensitivity detection method of ligand/receptor reaction |
US5491068A (en) | 1991-02-14 | 1996-02-13 | Vicam, L.P. | Assay method for detecting the presence of bacteria |
AU2115092A (en) | 1991-10-08 | 1993-04-22 | Eastman Kodak Company | Method, test device and kit for assay of specific binding ligand using controlled flow through filtration membrane |
US5290707A (en) | 1991-11-25 | 1994-03-01 | The United States Of America As Represented By The Secretary Of The Army | Method for detection of microorganisms |
US5256542A (en) | 1992-03-09 | 1993-10-26 | Tanox Biosystems, Inc. | Selecting low frequency antigen-specific single B lymphocytes with correction for background noise |
WO1993019199A1 (en) | 1992-03-20 | 1993-09-30 | Celsis Limited | Method and apparatus for the analysis of biological material |
US5422277A (en) | 1992-03-27 | 1995-06-06 | Ortho Diagnostic Systems Inc. | Cell fixative composition and method of staining cells without destroying the cell surface |
AU678179B2 (en) * | 1992-07-28 | 1997-05-22 | Steven Kessler | Methods for positive immunoselection of stem cells |
ES2123063T3 (en) | 1992-09-14 | 1999-01-01 | Stanford Res Inst Int | UPGRADED CONVERTER MARKERS FOR BIOLOGICAL TESTS AND OTHERS THROUGH LASER EXCITATION TECHNIQUES. |
AU2593192A (en) | 1992-09-14 | 1994-04-12 | Oystein Fodstad | Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations |
FR2700010B1 (en) | 1992-12-24 | 1995-03-17 | Rocher Yves Biolog Vegetale | Method and device for testing the reactivity of cells with regard to products. |
US5374531A (en) | 1993-03-22 | 1994-12-20 | Zynaxis, Inc. | Immunoassay for determination of cells |
US5514340A (en) | 1994-01-24 | 1996-05-07 | Magnetix Biotechnology, Inc. | Device for separating magnetically labelled cells |
NO180658C (en) | 1994-03-10 | 1997-05-21 | Oeystein Fodstad | Method and Device for Detecting Specific Target Cells in Specialized or Mixed Cell Populations and Solutions Containing Mixed Cell Populations |
US5968753A (en) * | 1994-06-14 | 1999-10-19 | Nexell Therapeutics, Inc. | Positive and positive/negative cell selection mediated by peptide release |
AUPN214095A0 (en) | 1995-04-03 | 1995-04-27 | Australian Water Technologies Pty Ltd | Method for detecting microorganisms using flow cytometry |
-
1996
- 1996-03-13 NO NO961031A patent/NO961031D0/en unknown
-
1997
- 1997-03-12 WO PCT/NO1997/000074 patent/WO1997033611A1/en not_active Application Discontinuation
- 1997-03-12 US US09/125,751 patent/US7198787B2/en not_active Expired - Fee Related
- 1997-03-12 SK SK1257-98A patent/SK125798A3/en unknown
- 1997-03-12 CA CA002248620A patent/CA2248620A1/en not_active Abandoned
- 1997-03-12 IL IL12601497A patent/IL126014A0/en unknown
- 1997-03-12 EP EP97916665A patent/EP0954329B1/en not_active Expired - Lifetime
- 1997-03-12 RU RU98118574/14A patent/RU2182493C2/en not_active IP Right Cessation
- 1997-03-12 JP JP9532482A patent/JP2000507230A/en active Pending
- 1997-03-12 AT AT97916665T patent/ATE222122T1/en not_active IP Right Cessation
- 1997-03-12 DE DE69714775T patent/DE69714775T2/en not_active Expired - Fee Related
- 1997-03-12 NZ NZ331763A patent/NZ331763A/en unknown
- 1997-03-12 TR TR1998/01795T patent/TR199801795T2/en unknown
- 1997-03-12 CN CN97194599A patent/CN1218411A/en active Pending
- 1997-03-12 PL PL97328804A patent/PL328804A1/en unknown
- 1997-03-12 AU AU25229/97A patent/AU710184B2/en not_active Ceased
- 1997-03-12 HU HU9901597A patent/HUP9901597A3/en unknown
- 1997-03-12 BR BR9708049A patent/BR9708049A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Blacher et al. | Squamous cell carcinoma of renal pelvis | |
Frost et al. | A phase I/IB trial of murine monoclonal anti‐GD2 antibody 14. G2a plus interleukin‐2 in children with refractory neuroblastoma: a report of the Children's Cancer Group | |
RU98118574A (en) | METHOD OF DESTRUCTION OF UNWANTED TARGET CELLS | |
BRPI0416028A (en) | compound, compound and antibody-drug conjugates, pharmaceutical compositions, uses of the conjugates, methods for treating cancer, an autoimmune disease, an infectious disease and a patient, method for inhibiting proliferation or killing the cells of tumor or cancer cells, tumor cell growth inhibition method, analysis to detect cancer cells and article of manufacture | |
RU2005130173A (en) | USE OF LECTINS FOR ACTIVATION OF OLIGOMERIZATION OF Glycoproteins and Antigenic Molecules | |
Suster et al. | Dendritic fibromyxolipoma: clinicopathologic study of a distinctive benign soft tissue lesion that may be mistaken for a sarcoma | |
RU2113224C1 (en) | Polypeptide substance, method of its preparing and pharmaceutical composition showing antitumor and analgetic activity | |
Jhavar et al. | Primary extranodal mucosa associated lymphoid tissue (MALT) lymphoma of the prostate | |
Dayan et al. | Ancient neurilemmoma (schwannoma) of the oral cavity | |
Holden et al. | The detection of endothelial cell antigens in cutaneous tissue using methacarn and periodate lysine paraformaldehyde fixation | |
WO2002053700A3 (en) | Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof | |
HUP9901597A2 (en) | Method of killing target cells in harvested cell populations with one or more immuno-toxins | |
EP0112093A2 (en) | Novel monoclonal hybridoma and corresponding antibody | |
Merrin et al. | Immune response in bladder cancer | |
Gallee et al. | Characterization of monoclonal antibodies raised against the prostatic cancer cell line PC‐82 | |
EP1696028A3 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
Sundström et al. | Radio-immunolocalization in nude mice using anticytokeratin monoclonal antibodies | |
Order | Ovarian Tumor Antigens: A New Potential for Therapy SE Order, MD, 3, 4 J. Thurston, ³ and R. Knapp, MD 5 SUMMARY-A murine tumor-associated a-globulin was identified by immunofluorescence, cytotoxicity, and immunoelectrophore-sis. The antiserum resulting from heterologous immunization | |
Holden | Histogenesis of Kaposi's sarcoma and angiosarcoma of the face and the scalp | |
YU63702A (en) | Novel antibody with specificity for colon cancer | |
Terry et al. | Cystic adventitial disease | |
Sasadaira et al. | Immunohistochemical identification of actomyosin‐containing (myoepithelial) cells in non‐neoplastic and neoplastic tissues | |
Stuart et al. | Development of the nephrotic syndrome in a patient with prostatic carcinoma | |
Lundbeck et al. | Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin: initial treatment results and the long-term course | |
Bakotic et al. | Aggressive epithelioid hemangioendothelioma of the lower extremity: a case report and review of the literature |